VU LSC-EMBL Partnership for Genome Editing Technologies
5 (737) · € 29.00 · En Stock
EMBL and VU LSC, recognising the scientific and technological potential of uniting their complementary strengths in the field of targeted genome modification, decided to intensify existing links and build further institutional synergies by creating the Partnership for Genome Editing Technologies.
VU LSC-EMBL PI Researcher P. Pausch Receives EMBO Installation Grant
Genetically encoded phosphatidylserine biosensor for in vitro, ex vivo and in vivo labelling, Cellular & Molecular Biology Letters
News
About Tutkus Lab
Laboratory of Dr Stephen Knox Jones
Research Plans in EMBL's Programme for 2022–2026, 'Molecules to Ecosystems' by European Molecular Biology Laboratory (EMBL) - Issuu
Short prokaryotic Argonautes provide defence against incoming mobile genetic elements through NAD+ depletion
partnerships Archives, Page 5 of 9
Genetically encoded phosphatidylserine biosensor for in vitro, ex vivo and in vivo labelling, Cellular & Molecular Biology Letters
genome editing Archives
Diverse virus-encoded CRISPR-Cas systems include streamlined genome editors - ScienceDirect
